1. Celestica's Q3 2024 report shows a 22% year-over-year revenue growth with a stunning 42% YoY expansion in the CCS segment; 2. The market is significantly raising revenue/EPS estimates following Celestica's internal expectations; 3. The stock is undervalued, with a fair value around $101, suggesting a 48% premium over the current price.